GoldenGolden
Advanced Search
MRL Ventures Fund

MRL Ventures Fund

MRL Ventures Fund, LLC is Merck's independent early-stage bio-therapeutics venture capital fund.

MRL Ventures Fund, LLC is Merck's independent early-stage bio-therapeutics venture capital fund. The firm has been in operation since 2004, in Cambridge, Massachusetts, United States.

The firm is interested in investing in seed and early-stage therapeutics companies, and breakthrough sciences that are created to deliver new medicines that improve human health. MRL Ventures Fund is interested in investing during Series A through C rounds in companies such as Imgo BioSciences, Entrada Therapeutics, Rheostat Therapeutics, and Kymera Therapeutics.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.